159 related articles for article (PubMed ID: 32871475)
1. A new lipophilic amino alcohol, chemically similar to compound FTY720, attenuates the pathogenesis of experimental autoimmune encephalomyelitis by PI3K/Akt pathway inhibition.
da Silva LC; Lima IVA; da Silva MCM; Corrêa TA; de Souza VP; de Almeida MV; de Oliveira ACP; Ferreira AP
Int Immunopharmacol; 2020 Nov; 88():106919. PubMed ID: 32871475
[TBL] [Abstract][Full Text] [Related]
2. Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis.
Giacoppo S; Pollastro F; Grassi G; Bramanti P; Mazzon E
Fitoterapia; 2017 Jan; 116():77-84. PubMed ID: 27890794
[TBL] [Abstract][Full Text] [Related]
3. Total flavonoids of astragalus attenuates experimental autoimmune encephalomyelitis by suppressing the activation and inflammatory responses of microglia via JNK/AKT/NFκB signaling pathway.
Yang L; Han X; Xing F; Wu H; Shi H; Huang F; Xu Q; Wu X
Phytomedicine; 2021 Jan; 80():153385. PubMed ID: 33091854
[TBL] [Abstract][Full Text] [Related]
4. Protecting effect of emodin in experimental autoimmune encephalomyelitis mice by inhibiting microglia activation and inflammation via Myd88/PI3K/Akt/NF-κB signalling pathway.
Zheng K; Lv B; Wu L; Wang C; Xu H; Li X; Wu Z; Zhao Y; Zheng Z
Bioengineered; 2022 Apr; 13(4):9322-9344. PubMed ID: 35287559
[TBL] [Abstract][Full Text] [Related]
5. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
Lee JH; Halperin-Sheinfeld M; Baatar D; Mughal MR; Tae HJ; Kim JW; Carter A; Lustig A; Snir O; Lavie G; Okun E; Mattson MP; Sredni B; Taub DD
Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426
[TBL] [Abstract][Full Text] [Related]
6. Huperzine A inhibits CCL2 production in experimental autoimmune encephalomyelitis mice and in cultured astrocyte.
Tian GX; Zhu XQ; Chen Y; Wu GC; Wang J
Int J Immunopathol Pharmacol; 2013; 26(3):757-64. PubMed ID: 24067473
[TBL] [Abstract][Full Text] [Related]
7. Natural triterpenes modulate immune-inflammatory markers of experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis.
Martín R; Hernández M; Córdova C; Nieto ML
Br J Pharmacol; 2012 Jul; 166(5):1708-23. PubMed ID: 22260389
[TBL] [Abstract][Full Text] [Related]
8. Maraviroc attenuates the pathogenesis of experimental autoimmune encephalitis.
Karampoor S; Zahednasab H; Amini R; Esghaei M; Sholeh M; Keyvani H
Int Immunopharmacol; 2020 Mar; 80():106138. PubMed ID: 32007705
[TBL] [Abstract][Full Text] [Related]
9. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE).
Karampoor S; Zahednasab H; Bokharaei-Salim F; Mirzaei R; Mojallal-Tabatabaei Z; Esghaei M; Keyvani H
Int Immunopharmacol; 2020 Jan; 78():105943. PubMed ID: 31830622
[TBL] [Abstract][Full Text] [Related]
11. Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K/Akt signaling pathway.
Liu SQ; Zhang ML; Zhang HJ; Liu FZ; Chu RJ; Zhang GX; Zhu L
Life Sci; 2017 Jul; 180():36-41. PubMed ID: 28499934
[TBL] [Abstract][Full Text] [Related]
12. Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: Involvement of the PI3K/Akt/GSK-3β pathway.
Sadek MA; Kandil EA; El Sayed NS; Sayed HM; Rabie MA
Int Immunopharmacol; 2023 Feb; 115():109647. PubMed ID: 36584570
[TBL] [Abstract][Full Text] [Related]
13. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
[TBL] [Abstract][Full Text] [Related]
14. Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-β in mouse experimental autoimmune encephalomyelitis.
Chiba K; Kataoka H; Seki N; Shimano K; Koyama M; Fukunari A; Sugahara K; Sugita T
Int Immunopharmacol; 2011 Mar; 11(3):366-72. PubMed ID: 20955831
[TBL] [Abstract][Full Text] [Related]
15. Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migration.
Ferrara G; Benzi A; Sturla L; Marubbi D; Frumento D; Spinelli S; Abbotto E; Ivaldi F; von Holtey M; Murone M; Nencioni A; Uccelli A; Bruzzone S
J Neuroinflammation; 2020 Jul; 17(1):228. PubMed ID: 32736564
[TBL] [Abstract][Full Text] [Related]
16. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
17. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
[TBL] [Abstract][Full Text] [Related]
18. Oral chitin treatment improved demyelination in murine autoimmune encephalomyelitis model by inhibition of inflammatory responses.
Mami S; Yeganeh F; Salari AA; Anissian A; Azizi M; Hajimollahoseini M
Int Immunopharmacol; 2020 Jul; 84():106536. PubMed ID: 32361654
[TBL] [Abstract][Full Text] [Related]
19. Genistein modulates the expression of Toll-like receptors in experimental autoimmune encephalomyelitis.
Dias AT; de Castro SBR; de Souza Alves CC; Evangelista MG; da Silva LC; Reis DRL; Machado MA; Juliano MA; Ferreira AP
Inflamm Res; 2018 Jul; 67(7):597-608. PubMed ID: 29687146
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior.
Kocovski P; Tabassum-Sheikh N; Marinis S; Dang PT; Hale MW; Orian JM
Front Immunol; 2021; 12():639650. PubMed ID: 34177891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
